Tag: #EliLilly
-
Lilly & Novo Nordisk Reach Landmark Pricing Agreement with U.S. Government on Obesity Drugs
As the battle for dominance in obesity treatment intensifies, Eli Lilly and Novo Nordisk are racing ahead with groundbreaking drugs. But with politics and market power in play, the story goes far beyond science — it’s shaping the future of healthcare itself.
-
Eli Lilly’s Major Netherlands Plant Investment: Scaling Supply for Oral Obesity Therapy
On November 4, 2025, Eli Lilly and Company announced a multi-billion-dollar investment in a new manufacturing facility in the Netherlands to support global rollout of its oral obesity drug orforglipron and fortify its trans-Atlantic production network.